Skip to Content

145 145 (Rivastigmine Tartrate 1.5 mg)

Pill with imprint 145 145 is Yellow, Capsule-shape and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Sun Pharmaceutical Industries Inc..

Rivastigmine is used in the treatment of alzheimer's disease; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 145 145

Rivastigmine Tartrate

145 145
1.5 mg
18.00 mm
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sun Pharmaceutical Industries Inc.
Inactive Ingredients
magnesium stearate, microcrystalline cellulose, silicon dioxide, gelatin, titanium dioxide, D&C Red No. 28, D&C Yellow No. 10, FD&C Yellow No. 6, shellac, alcohol, butyl alcohol, propylene glycol, ammonia, potassium hydroxide, ferrosoferric oxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
62756-0145 Sun Pharmaceutical Industries Inc.
68084-0550 Amerisource Health Services

Get help with Imprint Code FAQs.

Related Images for "145 145"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.